Nexalin Technology, Inc. (NXL) stock
NXLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$1.44−0.06 (-4.00%)
Close on Nov 18, 2026Market cap $31.73MP/E –Yield –
Nexalin Technology operating margin
Operating margin is operating income as a percentage of revenue.
Nexalin Technology's operating margin for the twelve months ending Jun 30, 2026 was -4202.5%. For fiscal 2025 it was -2781.7%, against -4596.1% the year before. The highest annual figure on record is -138.7% in fiscal 2022.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -2781.7% | +1814.4 |
| FY2024 | Dec 31, 2024 | -4596.1% | +547.3 |
| FY2023 | Dec 31, 2023 | -5143.5% | −5004.8 |
| FY2022 | Dec 31, 2022 | -138.7% | +4039.0 |
| FY2021 | Dec 31, 2021 | -4177.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -18479.7% | −16183.5 |
| Q1 FY2026 | Mar 31, 2026 | -14179.9% | −9276.3 |
| Q4 FY2025 | Dec 31, 2025 | -1403.9% | +9175.6 |
| Q3 FY2025 | Sep 30, 2025 | -12924.3% | −5962.2 |
| Q2 FY2025 | Jun 30, 2025 | -2296.2% | +2536.2 |
| Q1 FY2025 | Mar 31, 2025 | -4903.6% | −3538.8 |
| Q4 FY2024 | Dec 31, 2024 | -10579.5% | −8112.2 |
| Q3 FY2024 | Sep 30, 2024 | -6962.1% | −4411.6 |
| Q2 FY2024 | Jun 30, 2024 | -4832.4% | −2959.6 |
| Q1 FY2024 | Mar 31, 2024 | -1364.8% | −1311.0 |
| Q2 FY2023 | Jun 30, 2023 | -2467.2% | −2359.8 |
| Q1 FY2023 | Mar 31, 2023 | -2550.5% | −2434.5 |
| Q4 FY2022 | Dec 31, 2022 | -1872.8% | +533.5 |
| Q3 FY2022 | Sep 30, 2022 | -53.8% | +3154.1 |
| Q2 FY2022 | Jun 30, 2022 | -107.4% | – |
| Q1 FY2022 | Mar 31, 2022 | -116.0% | – |
| Q4 FY2021 | Dec 31, 2021 | -2406.3% | – |
| Q3 FY2021 | Sep 30, 2021 | -3207.9% | – |
See a number that looks wrong?